Filing Details

Accession Number:
0000880771-16-000190
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-30 16:41:18
Reporting Period:
2016-08-26
Filing Date:
2016-08-30
Accepted Time:
2016-08-30 16:41:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880771 Sciclone Pharmaceuticals Inc SCLN Pharmaceutical Preparations (2834) 943116852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1135041 T Nancy Chang 950 Tower Lane, Suite 900
Foster City CA 94404-2125
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-08-26 7,500 $10.25 17,540 No 4 S Indirect by Partnership
Common Stock Disposition 2016-08-29 10,000 $10.31 7,540 No 4 S Indirect by Partnership
Common Stock Disposition 2016-08-30 7,540 $10.33 0 No 4 S Indirect by Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Partnership
No 4 S Indirect by Partnership
No 4 S Indirect by Partnership
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 29,019 Direct